Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BFRI |
---|---|---|
09:43 ET | 1417 | 1.15 |
09:56 ET | 712 | 1.14 |
10:21 ET | 443 | 1.11 |
10:44 ET | 10478 | 1.18 |
10:46 ET | 13293 | 1.182 |
11:06 ET | 2200 | 1.2 |
11:09 ET | 539 | 1.24 |
11:11 ET | 4812 | 1.2325 |
11:13 ET | 6412 | 1.27 |
11:15 ET | 3064 | 1.2828 |
11:20 ET | 1900 | 1.2501 |
11:22 ET | 100 | 1.2501 |
11:26 ET | 3625 | 1.284 |
11:27 ET | 1399 | 1.3 |
11:33 ET | 6339 | 1.3616 |
11:36 ET | 200 | 1.34 |
11:38 ET | 11348 | 1.3296 |
11:40 ET | 4000 | 1.33 |
11:44 ET | 1500 | 1.2901 |
11:45 ET | 2340 | 1.27 |
11:47 ET | 107 | 1.2701 |
11:49 ET | 129 | 1.2701 |
11:54 ET | 5751 | 1.29 |
12:00 ET | 186 | 1.2899 |
12:03 ET | 1555 | 1.2891 |
12:07 ET | 4653 | 1.2891 |
12:14 ET | 1000 | 1.2601 |
12:25 ET | 1500 | 1.26 |
12:30 ET | 2000 | 1.28 |
12:32 ET | 2000 | 1.2767 |
12:36 ET | 5000 | 1.27 |
12:38 ET | 6000 | 1.2771 |
12:39 ET | 3499 | 1.27 |
12:41 ET | 100 | 1.27 |
12:45 ET | 3000 | 1.2946 |
12:48 ET | 300 | 1.3 |
12:50 ET | 1000 | 1.31 |
12:56 ET | 131 | 1.31 |
12:57 ET | 550 | 1.3075 |
01:06 ET | 213 | 1.3099 |
01:10 ET | 2018 | 1.31 |
01:30 ET | 100 | 1.34 |
01:39 ET | 100 | 1.3412 |
01:42 ET | 800 | 1.3401 |
01:48 ET | 1100 | 1.355 |
01:53 ET | 800 | 1.37 |
01:55 ET | 2454 | 1.37 |
01:57 ET | 327 | 1.37 |
02:00 ET | 5000 | 1.3895 |
02:02 ET | 13120 | 1.3892 |
02:04 ET | 5300 | 1.39 |
02:06 ET | 650 | 1.3968 |
02:09 ET | 3056 | 1.359 |
02:11 ET | 200 | 1.3675 |
02:13 ET | 1425 | 1.3903 |
02:15 ET | 600 | 1.35 |
02:18 ET | 1300 | 1.35 |
02:22 ET | 5250 | 1.4 |
02:27 ET | 3000 | 1.3702 |
02:38 ET | 150 | 1.4233 |
02:40 ET | 3580 | 1.43 |
02:42 ET | 6331 | 1.51 |
02:44 ET | 6696 | 1.46 |
02:45 ET | 740 | 1.4988 |
02:47 ET | 2655 | 1.4901 |
02:49 ET | 896 | 1.475 |
02:51 ET | 4302 | 1.495 |
02:54 ET | 4900 | 1.5205 |
02:56 ET | 9695 | 1.4801 |
02:58 ET | 200 | 1.52 |
03:00 ET | 1633 | 1.49 |
03:02 ET | 1263 | 1.5 |
03:03 ET | 6905 | 1.53 |
03:05 ET | 700 | 1.54 |
03:07 ET | 2894 | 1.55 |
03:12 ET | 1700 | 1.559 |
03:14 ET | 2118 | 1.5656 |
03:16 ET | 921 | 1.54 |
03:18 ET | 1100 | 1.54 |
03:23 ET | 500 | 1.54 |
03:25 ET | 534 | 1.52 |
03:27 ET | 100 | 1.5061 |
03:30 ET | 1982 | 1.51 |
03:32 ET | 120 | 1.5493 |
03:34 ET | 200 | 1.524 |
03:36 ET | 3800 | 1.5499 |
03:39 ET | 205 | 1.53 |
03:41 ET | 1100 | 1.54 |
03:48 ET | 1166 | 1.5001 |
03:50 ET | 100 | 1.53 |
03:52 ET | 100 | 1.5499 |
03:54 ET | 1828 | 1.52 |
03:56 ET | 500 | 1.51 |
03:57 ET | 5368 | 1.54 |
03:59 ET | 1231 | 1.54 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biofrontera Inc | 7.8M | -0.1x | --- |
Bon Natural Life Ltd | 5.7M | 0.8x | +78.05% |
Health-Chem Corp | 1.2K | 0.0x | --- |
Microalliance Group Inc | 36.6M | 4.4x | --- |
Neurobiological Technologies Inc | 30.0 | 0.0x | --- |
Gelesis Holdings Inc | 1.5M | 0.0x | --- |
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.8M |
---|---|
Revenue (TTM) | $34.1M |
Shares Outstanding | 5.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-15.19 |
Book Value | $3.16 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -44.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.